Pediatric and young adult patients and oncofertility

Katherine E. Dillon, Clarisa R. Gracia

Research output: Contribution to journalArticlepeer-review

Abstract

With improving survival rates for pediatric and young adult cancer patients, considerations regarding the long-Term effects of therapy have become more important. Cancer therapies are known to pose reproductive risks, though the effects may be unpredictable. All at-risk patients should have a discussion about potential treatment-related infertility before the onset of cancer therapy, and should be offered appropriate fertility preservation options. Embryo and sperm cryopreservation are considered standard therapy, though oocyte cryopreservation is gaining acceptance. Ovarian tissue cryopreservation, while still experimental, is showing great promise. It is the only option currently available to prepubertal girls. No fertility preservation options exist for prepubertal boys though some institutions may offer experimental testicular tissue cryopreservation.

Original languageEnglish (US)
Pages (from-to)161-173
Number of pages13
JournalCurrent treatment options in oncology
Volume13
Issue number2
DOIs
StatePublished - Jun 2012
Externally publishedYes

Keywords

  • Fertility Preservation
  • Gonads
  • Oncofertility
  • Reproductive risks

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Pediatric and young adult patients and oncofertility'. Together they form a unique fingerprint.

Cite this